Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for the polymorphic oxidation of debrisoquine in the Thai population.

British journal of clinical pharmacology - 1 Feb 1990

Wanwimolruk S, Patamasucon P, Lee E J

Abstract excerpt

Debrisoquine polymorphism has been studied extensively in Caucasian populations. The prevalence of the poor metaboliser phenotype is 3-10% in European and American Caucasian populations but appears to be very low in Asian populations. This study was carried out to determine the metabolic oxidation status in 173 Thai subjects. Phenotyping was performed using the metabolic ratio (MR) calculated as the 0-8 h urinary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Sex Factors
Share to Adolescent
Share to Debrisoquin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oxidation-Reduction

Share to Phenotype

Share to Polymorphism, Genetic

Share to Smoking

Share to Thailand

Source

Open in PubMed Open full text

Identifiers

PMID: 2306417
DOI: 10.1111/j.1365-2125.1990.tb03627.x
PMCID: PMC1380091

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for the polymorphic oxidation of debrisoquine in the Thai population.PMID 2306417Read ↗

Polymorphic debrisoquin metabolism in a Turkish population.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.Semantic proximity Read ↗

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.Semantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.Semantic proximity Read ↗

Polymorphism of debrisoquine oxidation in New Zealand Caucasians.Semantic proximity Read ↗

Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.Semantic proximity Read ↗

Effect of diurnal variation on debrisoquine metabolic phenotyping.Semantic proximity Read ↗

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.Semantic proximity Read ↗

CYP2D6 phenotypes among Malays in Malaysia.Semantic proximity Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.